Department of Chemical Pathology, Jos University Teaching Hospital, Plateau State, Nigeria.
Department of Radiology, Jos University Teaching Hospital, Plateau State, Nigeria.
Pan Afr Med J. 2020 Dec 31;37:388. doi: 10.11604/pamj.2020.37.388.21073. eCollection 2020.
human immunodeficiency virus (HIV) is evolving into a leading cause of cardiovascular diseases (CVD) in sub-Saharan Africa (SSA) where the burden of HIV remains high. Atherosclerosis underlie progression to CVD. We therefore examined the prevalence of subclinical atherosclerosis and its association with traditional and non-traditional risk factors for CVD in Nigerian HIV-infected adults.
this was a cross-sectional study involving randomly selected stable HIV-infected patients with undetectable viral load attending HIV clinics at the Jos University Teaching Hospital and Faith Alive Foundation in Jos, Nigeria. Demographic data, biophysical measurements, cardiovascular risk factors and information regarding HIV-related factors, fasting serum lipid profile, fasting plasma glucose, high-sensitivity C-reactive protein and Carotid-Intima-Media-Thickness (CIMT) were assessed. Subclinical atherosclerosis was defined using a cut-off value of mean CIMT ≥ 0.78 mm. Data were analyzed with the Statistical Package for Social Sciences® (SPSS) software version 23.0 (IBM Corp., Chicago, Illinois, USA). Bivariate analysis and multivariate logistic regression were used to examine the association between risk factors of CVD and subclinical atherosclerosis. The statistical significance level was set at p ≤ 0.05.
a total of 148 HIV adults (70.9% being females) on Anti-Retroviral Therapy (ART) were included in this study. The prevalence of subclinical atherosclerosis was 7.4%. Among subjects with subclinical atherosclerosis (SCA), 63.6% were males and 81.8% were hypertensive. Elevated blood glucose, lipids and high-sensitivity C-reactive protein, body mass index (BMI), HIV-related parameters (duration of HIV infection, antiretroviral regimen, CD4+ cell count), current smoking status, alcohol use, were not significantly associated with subclinical atherosclerosis (p>0.05). Male gender [OR(95%CI=4.91(1.36-17.77)], age [OR(95%CI)=1.14(1.06-1.23)], hypertension [OR(95%CI=14.4(3.03-71.86)] and metabolic syndrome [OR(95%CI=8.34(1.73-40.18)] were significantly associated with SCA at bivariate analysis. After adjusting for age, sex and antiretroviral regimen, only increasing age [Adjusted Odds Ratio (AOR) (95% confidence interval (CI)] = 1.12(1.01-1.25)] and hypertension [AOR (95%CI)=10.67 (1.31-87.18)], remained as independent predictors of subclinical atherosclerosis (SCA).
the prevalence of subclinical atherosclerosis among HIV-infected adults is high in Nigeria. It is significantly associated with increasing age and hypertension. Traditional CVD risk factors such as dyslipidaemia, diabetes mellitus and obesity were not associated with subclinical atherosclerosis in this population.
人类免疫缺陷病毒(HIV)正在成为撒哈拉以南非洲(SSA)心血管疾病(CVD)的主要病因,而该地区的 HIV 负担仍然很高。动脉粥样硬化是 CVD 进展的基础。因此,我们研究了尼日利亚 HIV 感染成年人亚临床动脉粥样硬化的流行情况及其与 CVD 的传统和非传统危险因素的关系。
这是一项横断面研究,涉及在尼日利亚乔斯大学教学医院和乔斯信仰复兴基金会接受 HIV 诊所治疗的稳定 HIV 感染患者,他们的病毒载量无法检测。评估了人口统计学数据、生物物理测量、心血管危险因素以及与 HIV 相关的因素、空腹血清脂质谱、空腹血糖、高敏 C 反应蛋白和颈动脉内膜中层厚度(CIMT)信息。使用平均 CIMT≥0.78mm 的截断值定义亚临床动脉粥样硬化。使用社会科学统计软件包®(SPSS)软件版本 23.0(IBM 公司,伊利诺伊州芝加哥)进行数据分析。使用双变量分析和多变量逻辑回归来检查 CVD 危险因素与亚临床动脉粥样硬化之间的关联。统计显著性水平设置为 p≤0.05。
本研究共纳入 148 名接受抗逆转录病毒治疗(ART)的 HIV 成年患者(70.9%为女性)。亚临床动脉粥样硬化的患病率为 7.4%。在患有亚临床动脉粥样硬化(SCA)的患者中,63.6%为男性,81.8%为高血压患者。血糖、血脂和高敏 C 反应蛋白升高、体重指数(BMI)、与 HIV 相关的参数(HIV 感染持续时间、抗逆转录病毒方案、CD4+细胞计数)、当前吸烟状况、饮酒与亚临床动脉粥样硬化无显著相关性(p>0.05)。男性[OR(95%CI)=4.91(1.36-17.77)]、年龄[OR(95%CI)=1.14(1.06-1.23)]、高血压[OR(95%CI)=14.4(3.03-71.86)]和代谢综合征[OR(95%CI)=8.34(1.73-40.18)]在双变量分析中与 SCA 显著相关。在校正年龄、性别和抗逆转录病毒方案后,只有年龄增长[调整后的优势比(AOR)(95%置信区间(CI))=1.12(1.01-1.25)]和高血压[AOR(95%CI)=10.67(1.31-87.18)]仍然是亚临床动脉粥样硬化(SCA)的独立预测因子。
在尼日利亚,HIV 感染成年人中亚临床动脉粥样硬化的患病率很高。它与年龄增长和高血压显著相关。在该人群中,传统的 CVD 危险因素如血脂异常、糖尿病和肥胖与亚临床动脉粥样硬化无关。